Skip to content
Open access

Synthesis and evaluation of 3,5-disubstituted isothiazolo[4,5-b]pyridines, pyrazolo[4,3-b]pyridines and isothiazolo[3,4-b]pyrazines as inhibitors of PIKfyve

Aug 2026 · Bioorganic chemistry (Print) · Vol 181, pp. 110337 - 110337 · 0 citations · 25 references
Medicine

TL;DR

Among the newly synthesized scaffolds, the isothiazolo[3,4-b]pyrazines were the most promising, displaying potent and selective PIKfyve inhibition in a biochemical assay, and, in addition, showing antiviral activity against SARS-CoV-2 (in the low μM range).

Abstract

Various 3,5-disubstituted isothiazolo[4,3-b]pyridines were previously shown to be potent inhibitors of the lipid kinase PIKfyve, displaying broad-spectrum antiviral activity. To further study their structure-activity relationship and to discover novel skeletons as antivirally active PIKfyve inhibitors, a scaffold hopping strategy was applied yielding isothiazolo[4,5-b]pyridines, pyrazolo[4,3-b]pyridines and isothiazolo[3,4-b]pyrazines. Among the newly synthesized scaffolds, the isothiazolo[3,4-b]pyrazines were the most promising, displaying potent and selective PIKfyve inhibition in a biochemical assay, and, in addition, showing antiviral activity against SARS-CoV-2 (in the low μM range). Finally, molecular docking of the various scaffolds in the ATP-binding site of PIKfyve allowed to rationalise their differences in PIKfyve inhibitory activity.

Read PDF

Similar papers

Open access 2026

SYNTHESIS, ANTIMICROBIAL EVALUATION, MOLECULARDOCKING, AND TOXICITY PREDICTIONOFN-BENZYLIDENE-1,2,4-TRIAZOLO[4,3-b]PYRIDAZINEDERIVATIVES

The comprehensive results based on the experimental and computational approaches revealed that these novel hybrids (5a-5k) represent promising scaffolds for the development of antimicrobial and other useful therapeutic drugs, thereby contributing to United Nations Sustainable Development Goal 3: Good Health and Well-be...

N. Devika, M. Mariyappan, J. S. Ruso et al. · 0 citations
Sep 2026

Synthesis, Crystal Structure, DFT, MEP, FMOs, Hirshfeld Analysis and Antitumor Activity Assay of 4-[(4-Fluorophenyl)amino]-6-pentylpyrido[4,3-d]pyrimidin-5(6H)-one

The results demonstrated that the DFT-optimized molecular structure is in good agreement with the crystal structure measured by X-ray single-crystal diffraction, thereby validating the reliability of the theoretical calculations.

Wei Zeng, Run-Tao Guo, Lan Jin et al. · 0 citations
Open access Sep 2026

Design, synthesis, molecular docking and anticancer activity of novel N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives

Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.

Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al. · 0 citations
Review Open access Oct 2026

Synthesis Strategies and Computational Activity Screening of Pyrazolo [3,4-B] Pyridine, Quinoline, and 1,2,4-Triazolo [1,5-A] Pyrimidine Scaffolds

The broad antimicrobial relevance of heterocyclic ring systems has been scarcely exploited, with three nitrogen-rich fused ring systems in particular – pyrazolo[3,4-b]pyridines (PYR), quinolines/polyhydroquinolines (QUIN), and 1,2,4-triazolo[1,5-a]pyrimidines (TAZ) – being highly underutilized. Recent synthetic and str...

Rane Dhiraj Dhanaji, Vikas Gupta · 0 citations
Review Open access Aug 2026

2-Sulfanylidene-2,3-dihydropyridopyrimidin-4(1H)-one Derivatives: Synthesis, Reactions and Biological Activities

This review presents a comprehensive examination of the syntheses, structural modifications, and biological activities of the 2-sulfanilidene-2,3-dihydropyridopyrimidin-4(1H)-one ring systems. The study is divided into four main sections covering compounds possessing the core structures of pyrido[2,3-d]-, pyrido[3,4-d]...

Ferhat Güneş, Özge Kuyrukçu Öztürk, Y. Dündar · 0 citations
Open access Sep 2026

Discovery of tricyclic benzo[4,5]imidazo[2,1-b]thiazole-3-hydroxyindolin-2-one hybrids as selective MAO-B and cholinesterase inhibitors

A series of 13 novel 3-hydroxyindolin-2-one-benzo[4,5]imidazo[2,1-b]thiazole hybrids was designed, synthesized, and evaluated as potential anti-Alzheimer agents targeting monoamine oxidase B (MAO-B) and cholinesterases. The target compounds were obtained by condensing a benzo[4,5]imidazo[2,1-b]thiazole-based ketone wit...

Wagdy M. Eldehna, Ashraf K. El-Damasy, Jaeyeop Lim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.